title: Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.
abstract: Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.
authors.affiliation: Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. ckotton@partners.org
authors.forename: Camille N
authors.initials: CN
authors.lastname: Kotton
authors.forename: Deepali
authors.initials: D
authors.lastname: Kumar
authors.forename: Angela M
authors.initials: AM
authors.lastname: Caliendo
authors.forename: Anders
authors.initials: A
authors.lastname: Asberg
authors.forename: Sunwen
authors.initials: S
authors.lastname: Chou
authors.forename: Lara
authors.initials: L
authors.lastname: Danziger-Isakov
authors.forename: Atul
authors.initials: A
authors.lastname: Humar
mesh_terms: D002648:Child; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D024882:Drug Resistance, Viral; D006801:Humans; D007390:International Agencies; D015166:Monitoring, Immunologic; D016377:Organ Transplantation / Q000009:adverse effects*; D011300:Preoperative Care; D012955:Societies, Medical; D014019:Tissue Donors; D014765:Viral Vaccines / Q000627:therapeutic use
chemical_list: D014765:Viral Vaccines